
An investigation for current long-term stockholders of shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) over potential breaches of fiduciary duties was announced and current long term NASDAQ:SCLN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com